Nesvacumab | Interleukin Related interleukin-related.com

Product Name :
Nesvacumab

Search keywords :
Nesvacumab

drugId :
null

Target Vo:
Angiopoietin-2

Target Vo Short Name :
ANGPT2

Moa_Name:
Angiopoietin-2 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Regeneron Pharmaceuticals Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Macular Degeneration

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
IRF3 Antibody
Ki67 Antibody (YA322)
iNOS Antibody: iNOS Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 131 kDa, targeting to iNOS. It can be used for ICC/IF,WB,IHC-F,IHC-P,ELISA assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts